$CHTP Recent News Wednesday’s movers: Herbalif
Post# of 89337
Posted On: 01/26/2014 11:22:35 PM
$CHTP Recent News
Wednesday’s movers: Herbalife slumps after call 4:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 6:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 12:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 9:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 7:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 7:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 11:10 a.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 1:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 7:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 6:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 10:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 11:15 a.m. July 26, 2011 - Val Brickates Kennedy
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Friday’s biggest advancing & declining stocks 2:55 p.m. June 10, 2011 - Kate Gibson
Drug stocks follow broader market south 12:10 p.m. June 10, 2011 - Val Brickates Kennedy
Chelsea Therapeutics soars on price target upgrade 9:01 a.m. June 10, 2011 - Val Brickates Kennedy
Monday’s biggest advancing and declining stocks 12:27 p.m. April 18, 2011 - MarketWatch
Wednesday’s biggest gaining and declining stocks 6:05 p.m. Feb. 2, 2011 - Kate Gibson
Telecom Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews 5:37 a.m. Jan. 21, 2014 - Zacks.com
Telecom Industry Stock Outlook - Jan 2014 - Industry Outlook 5:37 a.m. Jan. 21, 2014 - Zacks.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
A Few Minutes With Chelsea's CEO on Tuesday's Northera Panel and Future Plans 10:33 a.m. Jan. 17, 2014 - TheStreet.com
Stocks You Wish You Owned on January 15 10:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014 3:02 p.m. Jan. 16, 2014 - Seeking Alpha
Company news for January 16, 2014 - Corporate Summary 10:06 a.m. Jan. 16, 2014 - Zacks.com
Chelsea Therapeutics International (CHTP) Soars: Stock Up 91.7% - Tale of the Tape 9:39 a.m. Jan. 16, 2014 - Zacks.com
FDA Panel Backs CHTP's Northera - Analyst Blog 6:10 p.m. Jan. 15, 2014 - Zacks.com
Can Chelsea Live Up to Its Potential This Time? 11:20 a.m. Jan. 15, 2014 - 247WallSt.com
2 Biotech Stocks in Play: Celsion and Chelsea 11:14 a.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Sell-side weighs in as Chelsea Therapeutics soars 9:40 a.m. Jan. 15, 2014 - Seeking Alpha
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Jan. 15, 2014 - Zacks.com
Morning Market Movers 8:54 a.m. Jan. 15, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Chelsea Therapeutics' Northera Gets Strong Support From FDA Panel 7:58 a.m. Jan. 15, 2014 - WSJ.com
Chelsea Therapeutics soars on outlook for Northera 7:50 a.m. Jan. 15, 2014 - Seeking Alpha
CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets 5:19 a.m. Jan. 15, 2014 - InvestorPlace.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 4:11 p.m. Jan. 14, 2014 - benzinga.com
Early 2014 Advancing Companies with Expansion & New Distribution Opportunities: RiceBran, Whole Foods, Hain Celestial, DryShips and Chelsea Therapeutics 9:05 a.m. Jan. 16, 2014 - PR Newswire - PRF
Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals 11:02 a.m. Jan. 15, 2014 - ACCESSWIRE
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 5:09 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Clinical Findings Presentations, Stock Price Movements, and Addition to Indexes - Research Report on Acceleron, AcelRx, Antares, Chelsea Therapeutics, and Clovis 8:00 a.m. Jan. 6, 2014 - PR Newswire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Health Care Sector Insights: ZIOPHARM Oncology, Chelsea Therapeutics Intl., Antares Pharma, and Accuray 8:34 a.m. Dec. 19, 2013 - PR Newswire
Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Today's Research: ZIOPHARM Oncology Inc., Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, and Accuray Inc. 1:29 p.m. Nov. 22, 2013 - PR Newswire
Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics 8:00 a.m. Nov. 22, 2013 - PR Newswire
Chelsea Therapeutics Completes Public Offering of Common Stock 10:32 a.m. Nov. 18, 2013 - GlobeNewswire
BBEP, CHTP, XGTI and SNTA added to NASDAQ Active Stock Watch List at GSR 10:33 a.m. Nov. 13, 2013 - ACCESSWIRE
Chelsea Therapeutics Announces Pricing of Public Offering of Common Stock 8:45 a.m. Nov. 13, 2013 - GlobeNewswire
Chelsea Therapeutics Announces Public Offering of Common Stock 5:50 p.m. Nov. 12, 2013 - GlobeNewswire
Chelsea Therapeutics Reports Third Quarter 2013 Financial Results 4:23 p.m. Nov. 5, 2013 - GlobeNewswire
Morning Research: Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, Accuray Inc., and ZIOPHARM Oncology Inc. 8:11 a.m. Oct. 30, 2013 - PR Newswire
Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa) 3:01 p.m. Oct. 9, 2013 - GlobeNewswire
Early Briefing and Review: Accuray Inc., Chelsea Therapeutics Intl. Ltd, ZIOPHARM Oncology Inc., and Antares Pharma Inc. 8:40 a.m. Oct. 8, 2013 - PR Newswire
Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference 6:00 a.m. Sept. 19, 2013 - GlobeNewswire
Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission 3:01 p.m. Sept. 4, 2013 - GlobeNewswire
Wednesday’s movers: Herbalife slumps after call 4:57 p.m. Feb. 20, 2013 - Sue Chang
Chelsea Therapeutics CEO, other execs step down 6:17 a.m. July 10, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 12:00 p.m. May 31, 2012 - MarketWatch
Chelsea shares tumble on FDA setback 9:53 a.m. March 29, 2012 - MarketWatch.com
FDA seeks more info from Chelsea Therapeutics 7:22 a.m. March 29, 2012 - Greg Morcroft
Chelsea Therapeutics falls 23% in premarket 7:04 a.m. March 29, 2012 - Steve Gelsi
FDA decision nears for Chelsea Therapeutics 11:10 a.m. March 14, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Chelsea Therapeutics soars on FDA nod 1:13 p.m. Feb. 24, 2012 - Val Brickates Kennedy
Chelsea Therapeutics up 71% in premarket 7:58 a.m. Feb. 24, 2012 - Steve Gelsi
Stocks to watch Friday: Deckers, Salesforce, Crocs 6:49 a.m. Feb. 24, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:51 p.m. Feb. 13, 2012 - MarketWatch
Chelsea plunges 36% ahead of FDA update 10:54 a.m. Feb. 13, 2012 - Val Brickates Kennedy
Chelsea Therapeutics jumps 8% on ADHD study 11:15 a.m. July 26, 2011 - Val Brickates Kennedy
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Friday’s biggest advancing & declining stocks 2:55 p.m. June 10, 2011 - Kate Gibson
Drug stocks follow broader market south 12:10 p.m. June 10, 2011 - Val Brickates Kennedy
Chelsea Therapeutics soars on price target upgrade 9:01 a.m. June 10, 2011 - Val Brickates Kennedy
Monday’s biggest advancing and declining stocks 12:27 p.m. April 18, 2011 - MarketWatch
Wednesday’s biggest gaining and declining stocks 6:05 p.m. Feb. 2, 2011 - Kate Gibson
Telecom Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews 5:37 a.m. Jan. 21, 2014 - Zacks.com
Telecom Industry Stock Outlook - Jan 2014 - Industry Outlook 5:37 a.m. Jan. 21, 2014 - Zacks.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
A Few Minutes With Chelsea's CEO on Tuesday's Northera Panel and Future Plans 10:33 a.m. Jan. 17, 2014 - TheStreet.com
Stocks You Wish You Owned on January 15 10:42 p.m. Jan. 16, 2014 - WallStreetSectorSelector
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014 3:02 p.m. Jan. 16, 2014 - Seeking Alpha
Company news for January 16, 2014 - Corporate Summary 10:06 a.m. Jan. 16, 2014 - Zacks.com
Chelsea Therapeutics International (CHTP) Soars: Stock Up 91.7% - Tale of the Tape 9:39 a.m. Jan. 16, 2014 - Zacks.com
FDA Panel Backs CHTP's Northera - Analyst Blog 6:10 p.m. Jan. 15, 2014 - Zacks.com
Can Chelsea Live Up to Its Potential This Time? 11:20 a.m. Jan. 15, 2014 - 247WallSt.com
2 Biotech Stocks in Play: Celsion and Chelsea 11:14 a.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Sell-side weighs in as Chelsea Therapeutics soars 9:40 a.m. Jan. 15, 2014 - Seeking Alpha
Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog 9:31 a.m. Jan. 15, 2014 - Zacks.com
Morning Market Movers 8:54 a.m. Jan. 15, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Chelsea Therapeutics' Northera Gets Strong Support From FDA Panel 7:58 a.m. Jan. 15, 2014 - WSJ.com
Chelsea Therapeutics soars on outlook for Northera 7:50 a.m. Jan. 15, 2014 - Seeking Alpha
CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets 5:19 a.m. Jan. 15, 2014 - InvestorPlace.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 4:11 p.m. Jan. 14, 2014 - benzinga.com
Early 2014 Advancing Companies with Expansion & New Distribution Opportunities: RiceBran, Whole Foods, Hain Celestial, DryShips and Chelsea Therapeutics 9:05 a.m. Jan. 16, 2014 - PR Newswire - PRF
Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals 11:02 a.m. Jan. 15, 2014 - ACCESSWIRE
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH 5:09 p.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Clinical Findings Presentations, Stock Price Movements, and Addition to Indexes - Research Report on Acceleron, AcelRx, Antares, Chelsea Therapeutics, and Clovis 8:00 a.m. Jan. 6, 2014 - PR Newswire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Health Care Sector Insights: ZIOPHARM Oncology, Chelsea Therapeutics Intl., Antares Pharma, and Accuray 8:34 a.m. Dec. 19, 2013 - PR Newswire
Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH 7:00 a.m. Dec. 9, 2013 - GlobeNewswire
Today's Research: ZIOPHARM Oncology Inc., Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, and Accuray Inc. 1:29 p.m. Nov. 22, 2013 - PR Newswire
Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics 8:00 a.m. Nov. 22, 2013 - PR Newswire
Chelsea Therapeutics Completes Public Offering of Common Stock 10:32 a.m. Nov. 18, 2013 - GlobeNewswire
BBEP, CHTP, XGTI and SNTA added to NASDAQ Active Stock Watch List at GSR 10:33 a.m. Nov. 13, 2013 - ACCESSWIRE
Chelsea Therapeutics Announces Pricing of Public Offering of Common Stock 8:45 a.m. Nov. 13, 2013 - GlobeNewswire
Chelsea Therapeutics Announces Public Offering of Common Stock 5:50 p.m. Nov. 12, 2013 - GlobeNewswire
Chelsea Therapeutics Reports Third Quarter 2013 Financial Results 4:23 p.m. Nov. 5, 2013 - GlobeNewswire
Morning Research: Antares Pharma Inc., Chelsea Therapeutics Intl. Ltd, Accuray Inc., and ZIOPHARM Oncology Inc. 8:11 a.m. Oct. 30, 2013 - PR Newswire
Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa) 3:01 p.m. Oct. 9, 2013 - GlobeNewswire
Early Briefing and Review: Accuray Inc., Chelsea Therapeutics Intl. Ltd, ZIOPHARM Oncology Inc., and Antares Pharma Inc. 8:40 a.m. Oct. 8, 2013 - PR Newswire
Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference 6:00 a.m. Sept. 19, 2013 - GlobeNewswire
Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission 3:01 p.m. Sept. 4, 2013 - GlobeNewswire
(0)
(0)